Singapore, June 16 -- Singapore based molecular diagnostics company Lucence and the Agency for Science, Technology and Research (A*STAR) have announced study results indicating that the reagent used in Lucence's SAFERSample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection.

This proprietary reagent also stabilizes viral RNA at room temperature for up to one week. Together, these properties enable accessible, non-invasive, and safe sample collection via saliva, which is critical to scaling cost-effective testing worldwide. The reagent used in Lucence's SAFER Sample kit was invented at A*STAR's Institute of Bioengineering and Nanotechnology.

The SAFER Sample Collection Kit is registered as a Class A medic...